Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Infinity Pharmaceuticals (NQ: INFI ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, Sep 13, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Infinity Pharmaceuticals < Previous 1 2 3 4 5 6 7 8 Next > Infinity Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business Update November 14, 2022 From Infinity Pharmaceuticals, Inc. Via Business Wire Infinity Pharmaceuticals Provides MARIO-3 Update in Patients with Front Line Metastatic Triple Negative Breast Cancer Suggesting Potential Long-Term Patient Benefit of Eganelisib November 14, 2022 From Infinity Pharmaceuticals, Inc. Via Business Wire Infinity Pharmaceuticals Announces the Date of Its Third Quarter 2022 Financial Results Conference Call and Webcast November 07, 2022 From Infinity Pharmaceuticals, Inc. Via Business Wire Infinity to Participate in Wells Fargo and H.C. Wainwright Investor Conferences August 31, 2022 From Infinity Pharmaceuticals, Inc. Via Business Wire Why XPeng Shares Traded Lower By Around 11%; Here Are 77 Biggest Movers From Yesterday August 24, 2022 Gainers Via Benzinga This Technology Stock Jumped 55% Following Q2 Results; Here Are 96 Biggest Movers From Yesterday August 17, 2022 Gainers Eargo, Inc. (NASDAQ: EAR) jumped 77.2% to close at $2.02. The FDA finalized rule enabling access to over-the-counter hearing aids. Via Benzinga Why Invitae Climbed Around 279%; Here Are 98 Biggest Movers From Yesterday August 11, 2022 Gainers Invitae Corporation (NYSE: NVTA) surged 278.5% to close at $8.63 after the company reported better-than-expected Q2 EPS. Via Benzinga 12 Health Care Stocks Moving In Wednesday's After-Market Session August 10, 2022 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session August 10, 2022 Via Benzinga 11 Health Care Stocks Moving In Wednesday's Pre-Market Session August 10, 2022 Gainers Via Benzinga Infinity Pharmaceuticals: Q2 Earnings Insights August 09, 2022 Infinity Pharmaceuticals (NASDAQ:INFI) reported its Q2 earnings results on Tuesday, August 9, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Via Benzinga 12 Health Care Stocks Moving In Tuesday's After-Market Session August 09, 2022 Via Benzinga Why Plug Power Is Trading Higher By Around 14%, Here Are 73 Stocks Moving In Wednesday's Mid-Day Session August 10, 2022 Gainers BioAtla, Inc. (NASDAQ: BCAB) gained 50.1% to $5.42 following Q2 results. Euro Tech Holdings Company Limited (NASDAQ: CLWT) surged 39.5% to $2.0380. Via Benzinga Infinity Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update August 09, 2022 From Infinity Pharmaceuticals, Inc. Via Business Wire Infinity Pharmaceuticals Announces the Date of Its Second Quarter 2022 Financial Results Conference Call and Webcast August 02, 2022 From Infinity Pharmaceuticals, Inc. Via Business Wire 70 Biggest Movers From Friday May 31, 2022 Gainers Avadel Pharmaceuticals plc (NASDAQ: AVDL) shares climbed 133.6% to close at $2.50 on Friday. Avadel Pharmaceuticals shares dipped 68% on Thursday after announcing new FDA request for... Via Benzinga 81 Biggest Movers From Yesterday May 18, 2022 Gainers Eos Energy Enterprises, Inc. (NASDAQ: EOSE) shares gained 41.8% to settle at $1.90 on Tuesday. Eos Energy Enterprises recently reported worse-than-expected Q1 EPS and sales results. Via Benzinga Infinity Pharmaceuticals to Participate in Upcoming H.C. Wainwright Global Investment Conference May 17, 2022 From Infinity Pharmaceuticals, Inc. Via Business Wire Infinity Pharmaceuticals's Return On Capital Employed Insights May 13, 2022 Benzinga Pro data, Infinity Pharmaceuticals (NASDAQ:INFI) reported Q1 sales of $652.00 thousand. Earnings fell to a loss of $12.44 million, resulting in a 6.74% decrease from last quarter. Via Benzinga Infinity Pharmaceuticals: Q1 Earnings Insights May 03, 2022 Infinity Pharmaceuticals (NASDAQ:INFI) reported its Q1 earnings results on Tuesday, May 3, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Via Benzinga Infinity Pharmaceuticals Reports First Quarter 2022 Financial Results May 03, 2022 From Infinity Pharmaceuticals, Inc. Via Business Wire The Daily Biotech Pulse: FDA's AdComm For Acadia's Pimavanserin, Review Issues For Spero's Tebipenem Application, Cortexyme Layoffs May 03, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours. Via Benzinga 99 Biggest Movers From Yesterday May 12, 2022 Gainers Armstrong Flooring, Inc. (NYSE: AFI) shares jumped 237% to settle at $0.49 on Wednesday after a 13D filing showed Esopus Creek Advisors LLC disclosed a 5.1% active stake in the company. Via Benzinga Infinity Pharmaceuticals Earnings Preview May 02, 2022 Infinity Pharmaceuticals (NASDAQ:INFI) is set to give its latest quarterly earnings report on Tuesday, 2022-05-03. Here's what investors need to know before the announcement. Analysts estimate that... Via Benzinga Infinity Pharmaceuticals Announces the Date of Its First Quarter 2022 Financial Results Conference Call and Webcast April 26, 2022 From Infinity Pharmaceuticals, Inc. Via Business Wire Infinity Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) April 08, 2022 From Infinity Pharmaceuticals, Inc. Via Business Wire 12 Health Care Stocks Moving In Wednesday's Intraday Session March 30, 2022 Gainers Adagio Therapeutics (NASDAQ:ADGI) shares rose 40.0% to $5.39 during Wednesday's regular session. Trading volume for this security as of 13:31 EST is 80.0... Via Benzinga 51 Biggest Movers From Yesterday March 31, 2022 Gainers Forge Global Holdings, Inc. (NYSE: FRGE) jumped 73.9% to close at $37.64. Direct Digital Holdings, Inc. (NASDAQ: DRCT) shares surged 60.5% to close at $4.14 on Wednesday... Via Benzinga Infinity Pharmaceuticals Earnings Perspective: Return On Capital Employed March 30, 2022 Infinity Pharmaceuticals (NASDAQ:INFI) brought in sales totaling $451.00 thousand during Q4 according to data provided by Benzinga Pro. However, earnings decreased 8.76%, resulting in a loss of $11.65... Via Benzinga Infinity Pharmaceuticals Reports Full Year 2021 Financial Results and Provides Company Highlights March 29, 2022 From Infinity Pharmaceuticals, Inc. Via Business Wire < Previous 1 2 3 4 5 6 7 8 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.